» Articles » PMID: 33601876

Significance of a Polymerase Chain Reaction Method in the Detection of Clostridioides Difficile

Overview
Specialty Pharmacology
Date 2021 Feb 19
PMID 33601876
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Clostridioides difficile (CD) is the most common cause of nosocomial diarrhea. Detection of CD toxin in patients' faecal samples is the traditional rapid method for the diagnosis of CD infection. Various testing algorithms have been proposed: an initial screening test using a rapid test, and a confirmatory test (cytotoxicity neutralization assay, toxigenic culture, nucleic acid amplification test) for discordant results. The aim of this study was to evaluate the effectiveness of a two-step algorithm using an immunochromatographic test followed of a polymerase chain reaction (PCR).

Methods: The specimens have been tested according to the following schedule: 1) Step one: All samples were tested for detection of glutamate dehydrogenase antigen (GDH) and toxin A/B using the C. diff QUIK CHEK Complete test. All GDH and toxins positive results were considered CD positives; 2) Step two: When the results were discrepant (only GDH+ or toxins+), the samples were confirmed using the PCR test BD MAX Cdiff. All PCR positive results were considered CD positives.

Results: A total of 2,138 specimens were initially tested. 139 were positive for GDH and toxins. 160 discrepant results (148 GDH+ and 12 toxins+) were tested by PCR, 117 were positive (107/148 GDH+ and 10/12 toxins+).

Conclusions: The implementation of a PCR method showed an increase de 117 positive results (73.1% of discrepant). Considering the sensitivity of C.diff QUIK CHEK (instructions of manufacturer), the GDH discrepant results may be false negatives, y the samples PCR and toxins positives may be real positives results.

References
1.
Crobach M, Planche T, Eckert C, Barbut F, Terveer E, Dekkers O . European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2016; 22 Suppl 4:S63-81. DOI: 10.1016/j.cmi.2016.03.010. View

2.
Theiss A, Balla A, Ross A, Francis D, Wojewoda C . Searching for a Potential Algorithm for Clostridium difficile Testing at a Tertiary Care Hospital: Does Toxin Enzyme Immunoassay Testing Help?. J Clin Microbiol. 2018; 56(7). PMC: 6018335. DOI: 10.1128/JCM.00415-18. View

3.
Crobach M, Vernon J, Loo V, Kong L, Pechine S, Wilcox M . Understanding Clostridium difficile Colonization. Clin Microbiol Rev. 2018; 31(2). PMC: 5967689. DOI: 10.1128/CMR.00021-17. View

4.
Gillespie W, Marya N, Fahed J, Leslie G, Patel K, Cave D . in Inflammatory Bowel Disease: A Retrospective Study. Gastroenterol Res Pract. 2017; 2017:4803262. PMC: 5646328. DOI: 10.1155/2017/4803262. View

5.
Orellana-Miguel M, Alcolea-Medina A, Barrado-Blanco L, Rodriguez-Otero J, Chaves-Sanchez F . Algorithm proposal based on the C. Diff Quik Chek Complete ICT device for detecting Clostridium difficile infection. Enferm Infecc Microbiol Clin. 2012; 31(2):97-9. DOI: 10.1016/j.eimc.2012.01.003. View